Capital Fund Management (CFM)’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Capital Fund Management (CFM)’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-40,044	Closed	-$807K	–	1924
2021 Q3	$807K	Buy	+40,044	New	+$1.11M	0.01%	1256
2021 Q2	–	Sell	-40,613	Closed	-$1.04M	–	1725
2021 Q1	$1.04M	Sell	40,613 -7,173	-15%	-$183K	0.01%	955
2020 Q4	$1.05M	Buy	47,786 +7,709	+19%	+$170K	0.01%	975
2020 Q3	$721K	Buy	40,077 +1,520	+4%	+$31.5K	0.01%	958
2020 Q2	$979K	Sell	38,557 -23,648	-38%	-$509K	0.02%	697
2020 Q1	$1.14M	Sell	62,205 -12,933	-17%	-$251K	0.02%	733
2019 Q4	$1.66M	Buy	75,138 +47,511	+172%	+$956K	0.01%	911
2019 Q3	$397K	Buy	+27,627	New	+$395K	﹤0.01%	1334

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Capital Fund Management (CFM)'s DRNA Position: Q4 2021 in Review

Capital Fund Management (CFM) sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 40,044 shares — an estimated $807K sold.

Capital Fund Management (CFM) first reported a position in DRNA in Q3 2019 and held it in 8 quarters. The position peaked at $1.66M in Q4 2019. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Capital Fund Management (CFM) reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Capital Fund Management (CFM) sold 40,044 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $807K.
Capital Fund Management (CFM) first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2019 and held it in 8 quarters.
Capital Fund Management (CFM)'s Dicerna Pharmaceuticals, Inc. position peaked at $1.66M in Q4 2019.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2021, filed 10 Feb 2022.